Archit Organosys Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Archit Organosys Ltd is ₹ 37.73 as of 20 Mar 15:30 . The P/E Ratio of Archit Organosys Ltd is 10.9 as of March 2023 .The P/E Ratio of Saroja Pharma Industries India Ltd is 0 as of March 2023 . The Market Cap of Archit Organosys Ltd is ₹ 123.92 crore as of March 2023 .The Market Cap of Saroja Pharma Industries India Ltd is ₹ 0 crore as of March 2023 . The revenue of Archit Organosys Ltd for the Dec '25 is ₹ 39.3 crore as compare to the Sep '25 revenue of ₹ 34.32 crore. This represent the growth of 14.51% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Archit Organosys Ltd for the Dec '25 is ₹ 5.58 crore as compare to the Sep '25 ebitda of ₹ 4.16 crore. This represent the growth of 34.13% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Archit Organosys Ltd changed from ₹ 1.01 crore to ₹ 2.43 crore over 7 quarters. This represents a CAGR of 65.15% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Archit Organosys Ltd changed from 14.99 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Archit Organosys Ltd

Archit Organosys Limited was originally incorporated on 04th August 1993 as 'Shri Chlochem Limited'.
The Company got the name changed to Archit Organosys Limited from Shri Chlochem Limited effective from 19th May, 2012.
The Company is mainly engaged in the business of manufacturing and trading of various chemical products. Major customers of the Company include several large Indian and International companies who are engaged in the Agrochemical Manufacturing Sector, Pharmaceuticals Manufacturing Sector and Cosmetics Manufacturing Sector.
Company has developed various product like MCA, SMCA, CAC and TCAC. Company is selling their products across Pan India as well as USA, Europe, Latin America, Other Asian Countries and South Africa.
These products are used mainly in pharmaceutical Intermediates like Ibuprofen, Diclofenac, Aceclofenac, Oil field chemicals used for Oil Drilling mainly In CMC manufacturing, Agriculture field product majorly 2,4 D-Acid and many others, surfactants and cosmetic products as well as day to day personal use products, also used in Pigment.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Archit Organosys Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Archit Organosys Ltd or Saroja Pharma Industries India Ltd?

Market cap of Archit Organosys Ltd is 77 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Archit Organosys Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Archit Organosys Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Archit Organosys Ltd and Saroja Pharma Industries India Ltd?

As of March 22, 2026, the Archit Organosys Ltd stock price is INR ₹37.73. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Archit Organosys Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Archit Organosys Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.